Literature DB >> 6830865

Interaction of liposomes with human leukocytes in whole blood.

S H Kuhn, B Gemperli, E G Shephard, J R Joubert, P A Weidemann, G Weissmann, M C Finkelstein.   

Abstract

The uptake of multilamellar liposomes into human leukocytes in whole blood in vitro was evaluated on the basis of the cellular association of liposomal markers (3H-labelled cholesterol, lipid phase; [14C]inulin, aqueous phase). The entry of liposomes into human blood leukocytes was linear for 60 min and was mediated by a saturable mechanism displaying affinity constants of 0.28 +/- 0.17 and 0.16 +/- 0.05 mM liposomal lipid (means +/- S.E.) for liposomal lipid and aqueous phase markers, respectively. Amicon filtration analysis of incubation mixtures containing blood and liposomes (phosphatidylcholine:dicetyl phosphate:cholesterol, 70:20:10) showed that 34% of [14C]inulin was lost (neither liposome-associated nor cell-associated) after 60 min. By preincorporating sphingomyelin (35 mol%) into multilamellar liposomes, the leakage of the model aqueous phase marker inulin was reduced to 8% after 60 min, thus enhancing the drug carrier potential of liposomes in blood. As a consequence of their interaction with liposomes, the polymorphonuclear leukocytes in whole blood decreased in apparent buoyant density, while maintaining their viability. These results indicate that blood leukocytes in their natural milieu of whole blood are capable of interacting with, and taking up multilamellar liposomes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830865     DOI: 10.1016/0167-4889(83)90124-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  The Use of Lactose as an Alternative Coating for Nanoparticles.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2020-01-28       Impact factor: 3.534

2.  Inhibition of human neutrophil elastase activity by encapsulated serum (Serumsome) therapy.

Authors:  S H Kuhn; M C Finkelstein
Journal:  Appl Biochem Biotechnol       Date:  1984       Impact factor: 2.926

3.  Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes.

Authors:  M B Bally; R Nayar; D Masin; P R Cullis; L D Mayer
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Authors:  Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2018-07-17       Impact factor: 9.776

5.  Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase.

Authors:  J F Turrens; J D Crapo; B A Freeman
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

6.  A quantitative ex vivo study of the interactions between reconstituted high-density lipoproteins and human leukocytes.

Authors:  Dennis Pedersbæk; Katrine Jønsson; Ditte V Madsen; Sven Weller; Anja B Bohn; Thomas L Andresen; Jens B Simonsen
Journal:  RSC Adv       Date:  2020-01-23       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.